Видео ютуба по тегу Nmin-Analyse

Introduction to NMIN's NanoCore
Introduction to NMIN's NanoCore
Distillation: Rmin, Nmin, CAPEX and OPEX
Distillation: Rmin, Nmin, CAPEX and OPEX
Introduction to NMIN's eHTA Core Facility
Introduction to NMIN's eHTA Core Facility
rhAmpSeq™ CRISPR: Multiplexed Amplicon Sequencing & Analysis
rhAmpSeq™ CRISPR: Multiplexed Amplicon Sequencing & Analysis
Distillation Rmin versus Nmin (student errors)
Distillation Rmin versus Nmin (student errors)
Introduction to NMIN's PharmaCore
Introduction to NMIN's PharmaCore
Best practices in IP management: Introducing NMIN’s Step-by-Step Guide
Best practices in IP management: Introducing NMIN’s Step-by-Step Guide
NMIN Lecture with Dr. Pieter Cullis: Why be a scientific entrepreneur?
NMIN Lecture with Dr. Pieter Cullis: Why be a scientific entrepreneur?
Utilization of nanotechnology and chemotherapeutics to increase radiosensitivity of cancer cells
Utilization of nanotechnology and chemotherapeutics to increase radiosensitivity of cancer cells
Single-Particle Imaging to Quantitate Biophysical Properties of mRNA LNPs
Single-Particle Imaging to Quantitate Biophysical Properties of mRNA LNPs
Improved normalization of the Nanostring nCounter gene expression data
Improved normalization of the Nanostring nCounter gene expression data
Dose-dependencies in the plasma pharmacokinetics of a long-circulating porphyrin-lipid based NP
Dose-dependencies in the plasma pharmacokinetics of a long-circulating porphyrin-lipid based NP
Beyond safety & efficacy: Why successful commercialization depends on more than clinical trials data
Beyond safety & efficacy: Why successful commercialization depends on more than clinical trials data
Effectively Communicating the Impact of your Research
Effectively Communicating the Impact of your Research
Position your health technology for success
Position your health technology for success
Intro to Business Models: Dr. Jon Thomas
Intro to Business Models: Dr. Jon Thomas
Nanomedicines for Gene Therapy: Optimization of Lipid Nanoparticles for Therapeutic Genome Editing
Nanomedicines for Gene Therapy: Optimization of Lipid Nanoparticles for Therapeutic Genome Editing
Bill Duong: Development of a microfluidic chip for exosomal PD-L1 analysis in lung cancer
Bill Duong: Development of a microfluidic chip for exosomal PD-L1 analysis in lung cancer